Intestinal Ralstonia pickettii augments glucose intolerance in obesity.

Autor: Shanthadevi D Udayappan, Petia Kovatcheva-Datchary, Guido J Bakker, Stefan R Havik, Hilde Herrema, Patrice D Cani, Kristien E Bouter, Clara Belzer, Julia J Witjes, Anne Vrieze, Eleanore Susanne Victoria de Sonnaville, Alice Chaplin, Daniel H van Raalte, Steven Aalvink, Geesje M Dallinga-Thie, Hans G H J Heilig, Göran Bergström, Suzan van der Meij, Bart A van Wagensveld, Joost B L Hoekstra, Frits Holleman, Erik S G Stroes, Albert K Groen, Fredrik Bäckhed, Willem M de Vos, Max Nieuwdorp

Publikováno v: PLoS ONE, Vol 12, Iss 11, p e0181693 (2017)

An altered intestinal microbiota composition has been implicated in the pathogenesis of metabolic disease including obesity and type 2 diabetes mellitus (T2DM). Low grade inflammation, potentially initiated by the intestinal microbiota, has been sugg

Externí odkaz: https://doaj.org/article/814cfded566f4257bae435b4dd748e36

Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial

Autor: Willem M. de Vos, Lorenzo Piemonti, Andrei Prodan, Nordin M J Hanssen, Frank Stam, Suat Simsek, Bartjan Potter van Loon, Jacques J. Bergman, Evgeni Levin, Victor E. A. Gerdes, Martin Diekman, Catherina Brouwer, Bart O. Roep, Gaby Duinkerken, Sultan Imangaliyev, Valeria Sordi, Antoinette Joosten, Guido J. Bakker, Joost B. L. Hoekstra, Ilias Attaye, Daniël H. van Raalte, Arianne C. van Bon, Martin Gerding, Han Levels, Frits Holleman, Aeilko H. Zwinderman, Cees Rustemeijer, Roel P.L.M. Hoogma, Tanja Nikolic, Elena Rampanelli, Max Nieuwdorp, Bernadette S. de Bakker, Silvia Pellegrini, Pieter F. de Groot, Sytze van Dam

Publikováno v: Gut, 70(1), 92-105
de Groot, P, Nikolic, T, Pellegrini, S, Sordi, V, Imangaliyev, S, Rampanelli, E, Hanssen, N, Attaye, I, Bakker, G, Duinkerken, G, Joosten, A, Prodan, A, Levin, E, Levels, H, Potter van Loon, B, van Bon, A, Brouwer, C, van Dam, S, Simsek, S, van Raalte, D, Stam, F, Gerdes, V, Hoogma, R, Diekman, M, Gerding, M, Rustemeijer, C, de Bakker, B, Hoekstra, J, Zwinderman, A, Bergman, J, Holleman, F, Piemonti, L, de Vos, W, Roep, B & Nieuwdorp, M 2021, ' Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial ', Gut, vol. 70, no. 1, pp. 92-105 . https://doi.org/10.1136/gutjnl-2020-322630
Gut, 70(1):gutjnl-2020-322630, 92-105. BMJ Publishing Group
Gut, 70(1), 92-105. BMJ Publishing Group
Gut 70 (2020) 1

ObjectiveType 1 diabetes (T1D) is characterised by islet autoimmunity and beta cell destruction. A gut microbiota–immunological interplay is involved in the pathophysiology of T1D. We studied microbiota-mediated effects on disease progression in pa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb6a019d74c550ca3b4acaa1aca8c73c
https://research.wur.nl/en/publications/faecal-microbiota-transplantation-halts-progression-of-human-new-

Physicians report barriers to deliver best practice care for asplenic patients: a cross-sectional survey.

Autor: A J Jolanda Lammers, Joost B L Hoekstra, Peter Speelman, Kiki M J M H Lombarts

Publikováno v: PLoS ONE, Vol 6, Iss 3, p e17302 (2011)

BACKGROUND: Current management of asplenic patients is not in compliance with best practice standards, such as defined by the British Committee for Standards in Haematology. To improve quality of care, factors inhibiting best practice care delivery n

Externí odkaz: https://doaj.org/article/53cb633db4a144ccbe283189cfaf7e08

Hot heads & cool bodies: The conundrums of human brown adipose tissue (BAT) activity research

Autor: Joost B. L. Hoekstra, Jan Booij, Hein J. Verberne, Lonneke Bahler, Frits Holleman

Publikováno v: European journal of internal medicine. 40:26-29

Brown adipose tissue is able to increase energy expenditure by converting glucose and fatty acids into heat. Therefore, BAT is able to increase energy expenditure and could thereby facilitate weight loss or at least weight maintenance. Since cold is

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b643d179fe9042681927c8c543800344
https://doi.org/10.1016/j.ejim.2016.12.023

Add-on treatment with intermediate-acting insulin versus sliding-scale insulin for patients with type 2 diabetes or insulin resistance during cyclic glucocorticoid-containing antineoplastic chemotherapy: a randomized crossover study

Autor: Joost B. L. Hoekstra, Victor E. A. Gerdes, J. S. de Maar, Maaike C. Gerards, Titia M. Vriesendorp, Tessa G Steenbruggen

Publikováno v: Diabetes, obesity & metabolism, 18(10), 1041-1044. Wiley-Blackwell

The aim of this study was to compare the effectiveness and safety of intermediate-acting insulin (IMI) titrated on body weight and glucocorticoid dose with that of short-acting sliding-scale insulin (SSI) in patients on recurrent high-dose glucocorti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30e769b9aeff7bacfa041834bd2940ab
https://doi.org/10.1111/dom.12694